Efficient sleeping beauty DNA transposition from DNA minicircles
Nynne Sharma1, Yujia Cai, Rasmus O Bak
1Department of Biomedicine, Aarhus University, Aarhus, Denmark.
Molecular Therapy. Nucleic Acids
|February 28, 2013
Summary
DNA minicircles (MCs) offer a safer alternative for gene transfer, enhancing therapeutic potential. This study shows MCs improve Sleeping Beauty transposon delivery and stability in cells.
Area of Science:
- Gene therapy
- Molecular biology
- Biotechnology
Background:
- DNA transposon-based vectors show promise for therapeutic gene transfer, particularly in stem cells.
- Current plasmid DNA vectors raise safety concerns due to bacterial sequences.
- Optimizing Sleeping Beauty (SB) transposon vectors for clinical use is crucial.
Purpose of the Study:
- To evaluate DNA minicircles (MCs) as a backbone-free carrier for Sleeping Beauty (SB) DNA transposon transposition.
- To assess the efficiency of SB transposition from MCs compared to traditional plasmids.
- To enhance the safety and efficacy of SB transposon-based gene delivery systems.
Main Methods:
- Utilized DNA minicircles (MCs) as donor DNA for Sleeping Beauty (SB) transposition, devoid of bacterial plasmid sequences.
- Employed the hyperactive SB100X transposase to direct transposition from MC donors.
- Quantified stable transfection rates and analyzed the impact of donor size on transposition efficiency.
Main Results:
- Demonstrated potent DNA transposition from SB DNA minicircle (MC) donors.
- Significantly enhanced stable transfection rates by expressing SB100X transposase from MCs.
- Observed an inverse relationship between circular donor size and stable transfection rate, suggesting improved cellular uptake and expression with MCs.
Conclusions:
- DNA minicircles (MCs) are a safe and effective non-bacterial DNA source for Sleeping Beauty (SB) transposon transposition.
- MC-based SB transposition systems offer advantages in cellular uptake and expression, leading to enhanced stable transfection.
- MCs should be considered a standard DNA source for SB transposons in both therapeutic and research settings.
